← Back to Search

Income Supplements + Enhanced Care for Reducing Hospital Readmissions

N/A

Recruiting

Led By Rajan A Sonik, PhD, JD, MPH

Research Sponsored by AltaMed Health Services Corporation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 30 days of the index hospital discharge

Awards & highlights

Study Summary

This trial aims to reduce hospital readmissions by providing a post-discharge income supplement to vulnerable older adults in an enhanced care plan. It seeks to combine healthcare and social needs to improve healthcare delivery.

Who is the study for?

This trial is for older adults aged 55 or over who have been recently discharged from the hospital and are part of an enhanced care program. They must understand the consent form, be attending a clinic appointment within 10 days post-discharge, and not have a legal guardian controlling their finances.Check my eligibility

What is being tested?

The study tests if giving a one-time income supplement after leaving the hospital can reduce unplanned readmissions within 30 days for vulnerable seniors with complex medical needs, alongside improved care coordination.See study design

What are the potential side effects?

Since this trial involves income supplements and care planning rather than medications, there aren't typical drug side effects. However, participants may experience changes in stress levels or health due to financial relief.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 30 days of the index hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 30 days of the index hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days of the index hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Unplanned 30-day readmission

Secondary outcome measures

30-day post-discharge medical expenditures

30-day post-discharge medical readmission OR emergency department visit

90-day post-discharge medical expenditures

+2 more

Other outcome measures

Post-discharge care plan adherence

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment2 Interventions

Enhanced care planning plus a one-time $300 post-discharge income supplement

Group II: ControlActive Control1 Intervention

Enhanced care planning only (plus $15 as compensation for participation)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

AltaMed Health Services CorporationLead Sponsor

8 Previous Clinical Trials

31,201 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,585 Total Patients Enrolled

University of Southern CaliforniaOTHER

906 Previous Clinical Trials

1,595,876 Total Patients Enrolled

Media Library

Enhanced care planning Clinical Trial Eligibility Overview. Trial Name: NCT05807750 — N/A

Enhanced care planning 2023 Treatment Timeline for Medical Study. Trial Name: NCT05807750 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for applicants in this trial currently?

"According to clinicaltrials.gov, this medical trial is not in the process of recruiting patients at present. The research was first posted on May 1st 2023 and last edited on March 29th 2023. Although there are no active recruitment efforts for this study right now, 3 other trials have opened up enrollment opportunities for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects Of Income Supplements On 30-Day Readmissions For Vulnerable Older Adults

2023. "Effects Of Income Supplements On 30-Day Readmissions For Vulnerable Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05807750.